Abstract
Axyntis—a French pharmaceutical chemical company—and New Jersey-based PMC Group are vying to acquire Isochem, the French contract manufacturer of pharmaceutical chemicals spun out from state-owned SNPE in 2010. The firm is currently owned by Aurelius, a German industrial holding company. Isochem has four manufacturing sites in France. Axyntis operates seven manufacturing and research sites in France. PMC manufactures performance additives for drugs and other markets at plants in the U.S., Europe, and Asia. Isochem filed for receivership with the French commercial court earlier this year when Gilead Sciences canceled an order for a drug intermediate.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
